文献速递功能神经外科

立体定向放射外科治疗三叉神经痛的长期患者报告结局

Long-Term Patient-Reported Outcomes of Stereotactic Radiosurgery for Trigeminal Neuralgia.
PubMed 文献 · World Neurosurg · 2024-02-09

平均疼痛评分从术前4.1降至最佳1.1(P<0.001),中位随访50个月时仍为1.1(P<0.001)。作者认为立体定向放射外科安全有效,可实现持久疼痛缓解。

要点

  • 51例(76%)患者完成问卷,平均术前FPS评分为4.1(SD 1.1)。
  • 43例(83%)报告初始疼痛缓解,最佳FPS评分1.1(SD 1.5)(P<0.001),中位随访50个月时仍为1.1(SD 1.6)(P<0.001)。
  • 神经血管压迫与FPS评分改善相关(OR 5.7,95%CI 1.1-29.7,P=0.038)。

核心结论

  • 作者认为立体定向放射外科是安全有效的治疗方式,可实现持久疼痛缓解。

研究设计与样本

  • 回顾性分析2013年1月至2022年2月接受伽玛刀立体定向放射外科治疗的特发性或经典三叉神经痛患者,2022年末至2023年初发送问卷,分析收到的51例(76%)回复。

主要发现

  • 平均术前FPS评分为4.1(SD 1.1),43例(83%)报告初始疼痛缓解,最佳术后FPS评分为1.1(SD 1.5)(P<0.001)。
  • 中位随访50个月时FPS评分为1.1(SD 1.6)(P<0.001)。
  • 神经血管压迫与FPS评分改善相关(OR 5.7,95%CI 1.1-29.7,P=0.038)。
  • 面部感觉异常患者平均术前FPS评分为1.7(SD 2.0),末次随访时平均评分为1.4(SD 1.7)(P=0.32)。
  • 8例(15%)接受了术后干预,21例(40%)无需术后干预即不再需要药物治疗,44例(85%)报告对立体定向放射外科满意。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: We aimed to evaluate patient-reported outcomes (PROs) of stereotactic radiosurgery (SRS) for TN in terms of treatment efficacy and toxicity. METHODS: We retrospectively analyzed patients who underwent Gamma Knife SRS for idiopathic or classic TN between January 2013 and February 2022. Questionnaires regarding pain relief, treatment toxicity, and post-SRS treatment were sent between late 2022 and early 2023, and the responses received were analyzed. The Faces Pain Scale (FPS, 0: best, 5: worst) was used for quantitative evaluation. RESULTS: Responses were received from 51 patients (76%). The mean pre-SRS FPS score was 4.1 (standard deviation (SD) 1.1). Forty-three patients (83%) reported initial pain relief and the best post-SRS FPS score was 1.1 (SD 1.5) (P < 0.001). At a median follow-up of 50 months, the FPS score was still 1.1 (SD 1.6) (P < 0.001). Analysis of factors contributing to durable pain relief showed neurovascular compression to be associated with FPS score improvement (Odds ratio 5.7, 95% CI 1.1-29.7, P = 0.038). Facial dysesthesia had a mean pre-SRS FPS score of 1.7 (SD 2.0) and a mean score of 1.4 (SD 1.7) at the last follow-up (P = 0.32). Eight patients (15%) received post-SRS interventions and 21 (40%) no longer required pharmacotherapy without post-SRS intervention. Forty-four patients (85%) reported being satisfied with SRS. CONCLUSIONS: We analyzed PROs of SRS for TN using the FPS and showed SRS to be a safe and effective treatment modality achieving long lasting pain relief.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Yomo S, Oda K, Oguchi K, et al. Long-Term Patient-Reported Outcomes of Stereotactic Radiosurgery for Trigeminal Neuralgia. World Neurosurg. 2024. PMID: 38342166. doi:10.1016/j.wneu.2024.02.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。